The FDA gave clearance to Valeant Pharmaceuticals' Restylane Silk injectable gel with 0.3% lidocaine for lip augmentation and correction of perioral rhytids in patients at least 21 years old.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||